A drug called Dexamethasone could reduce COVID-19 deaths by at least one third, researchers at the University of Oxford said in a new study on Tuesday.
According to the researchers, Dexamethasone only helps in severe cases of COVID-19, and is taken either orally or through an IV.
The Food and Drug Administration (FDA) recently recalled emergency approval of the hydroxichloroquine in treatment of the coronavirus.
[read_more id="2" more="Read full article" less="Read less"]
President Donald Trump has been touting hydroxicloroquine, a drug used to treat malaria, as a potential treatment for COVID-19, the respiratory disease caused by the novel coronavirus.
Dexamethasone, a drug used since early 1960s, is inexpensive and reduces inflammation in COVID-19 patients. Researchers believe that it can prevent 1/8th of deaths in patients on breathing machines.
For high risk patients, the drug is shown to be most beneficial as it appears to help stop some of the damage caused when the body’s immune system into overdrive. The only other drug that has also proven beneficial in recent studies is Remdesivir, which is used to treat ebola. However, there is not strong evidence that it reduces mortality.
According to the BBC, the world’s largest existing treatment testing trial continues in the battle against coronavirus most patients continue to recover without ever being admitted to the hospital.